Additional analyses examining NfL stratification specifically within participants showing AD-consistent biomarker profiles (low Aβ42/40 + high P-tau181) suggested similar potential for sample size reduction (N = 276 vs. 608). Here, NEFL is linked to Alzheimer disease.